Literature DB >> 7878772

The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation.

R Mañez1, R Mateo, J Tabasco, S Kusne, T E Starzl, R J Duquesnoy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7878772      PMCID： PMC2993506          DOI： 10.1097/00007890-199502270-00036

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  19 in total

1.  HLA matching in liver transplantation: a retrospective analysis.

Authors:  B K Gunson; M Hathaway; J A Buckels; A D Mayer; E Elias; P McMaster; J M Neuberger
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

2.  Relationship between HLA compatibility and first liver allograft survival. l'ESPRIT Study Group.

Authors:  J Thorogood
Journal:  Transplant Proc       Date:  1993-08       Impact factor: 1.066

3.  Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect?

Authors:  B H Markus; R J Duquesnoy; R D Gordon; J J Fung; M Vanek; G Klintmalm; C Bryan; D Van Thiel; T E Starzl
Journal:  Transplantation       Date:  1988-09       Impact factor: 4.939

4.  Variability in the expression of a beta 2-microglobulin epitope on hepatocytes in chronic type C hepatitis on treatment with interferon.

Authors:  L García-Buey; M López-Botet; A García-Sánchez; M A Balboa; J Aramburu; C García-Monzón; A Acevedo; R Moreno-Otero
Journal:  Hepatology       Date:  1993-03       Impact factor: 17.425

5.  Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection.

Authors:  A J Demetris; R Jaffe; D G Sheahan; J Burnham; J Spero; S Iwatsuki; D H Van Theil; T E Starzl
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

6.  Effect of corticosteroid therapy on levels of antibody to hepatitis B core antigen in patients with chronic type B hepatitis.

Authors:  M H Sjogren; J H Hoofnagle; J G Waggoner
Journal:  Hepatology       Date:  1987 May-Jun       Impact factor: 17.425

7.  Persistent hepatitis C viraemia without liver disease.

Authors:  S Brillanti; M Foli; S Gaiani; C Masci; M Miglioli; L Barbara
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

8.  Quantitation of hepatitis C virus RNA in liver transplant recipients.

Authors:  O Chazouilleres; M Kim; C Combs; L Ferrell; P Bacchetti; J Roberts; N L Ascher; P Neuwald; J Wilber; M Urdea
Journal:  Gastroenterology       Date:  1994-04       Impact factor: 22.682

9.  Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation.

Authors:  P T Donaldson; G J Alexander; J O'Grady; J Neuberger; B Portmann; M Thick; H Davis; R Y Calne; R Williams
Journal:  Lancet       Date:  1987-04-25       Impact factor: 79.321

10.  The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation.

Authors:  R Mañez; L T White; P Linden; S Kusne; M Martin; D Kramer; A J Demetris; D H Van Thiel; T E Starzl; R J Duquesnoy
Journal:  Transplantation       Date:  1993-05       Impact factor: 4.939
View more
  10 in total

Review 1.  Hepatitis C and liver transplantation.

Authors:  M Berenguer; T L Wright
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

Review 2.  Living donor liver transplantation to patients with hepatitis C virus cirrhosis.

Authors:  Yasuhiko Sugawara; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

3.  Antithymocyte globulin induction therapy in hepatitis C-positive liver transplant recipients.

Authors:  Peter J Horton; Jean Tchervenkov; Jeff S Barkun; Caroline Rochon; Prosanto K Chaudhury; Tammy L Znajda; John B Martinie; Peter Metrakos
Journal:  J Gastrointest Surg       Date:  2005 Sep-Oct       Impact factor: 3.452

4.  Effect of nonviral factors on hepatitis C recurrence after liver transplantation.

Authors:  Andrew M Cameron; Rafik M Ghobrial; Jonathan R Hiatt; Ian C Carmody; Sherilyn A Gordon; Douglas G Farmer; Hasan Yersiz; Michael A Zimmerman; Francisco Durazo; Steve H Han; Sammy Saab; Jeffrey Gornbein; Ronald W Busuttil
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

Review 5.  Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.

Authors:  Alberto Grassi; Giorgio Ballardini
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

6.  Hepatic preservation injury: severity of hepatitis C recurrence and survival after liver transplantation.

Authors:  Anthony J Michaels; Renumathy Dhanasekaran; David P Foley; Ahmad Alkhasawneh; Lisa Dixon; Consuelo Soldevila-Pico; Giuseppe Morelli; Roniel Cabrera; Virginia C Clark; Roberto J Firpi
Journal:  Dig Dis Sci       Date:  2013-01-10       Impact factor: 3.199

7.  Liver transplantation and hepatitis C.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara
Journal:  Int J Hepatol       Date:  2012-07-26

8.  Role of living donor liver transplantation in the treatment of hepatitis C virus infection.

Authors:  Georgios Tsoulfas; Polyxeni Agorastou
Journal:  Hepat Mon       Date:  2011-06       Impact factor: 0.660

9.  Increased Surgical Complications but Improved Overall Survival with Adult Living Donor Compared to Deceased Donor Liver Transplantation: A Systematic Review and Meta-Analysis.

Authors:  Wei Tang; Jian-Guo Qiu; Yang Cai; Luo Cheng; Cheng-You Du
Journal:  Biomed Res Int       Date:  2020-08-24       Impact factor: 3.411

10.  Living-donor liver transplantation and hepatitis C.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara
Journal:  HPB Surg       Date:  2013-01-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.